Halothane

Halothane	Last updated: 15/04/2021
(Also known as: fluothane)

Data alerts

The following alerts are based on the data in the tables below. An absence of an alert does not imply the substance has no implications for human health, biodiversity or the environment but just that we do not have the data to form a judgement.

Environmental fate	Ecotoxicity	Human health
		Human health High alert: Reproduction/development effects; Neurotoxicant

GENERAL INFORMATION

Description

A substance used for inhalational anesthesia

Availability status

Introduction & key dates

1951, first synthesised

Examples of species treated

Horses, Domestic animals, Mammals, Birds and Reptiles.

Chemical structure

Isomerism

Chemical formula

₂HBrClF₃

Canonical SMILES

C(C(F)(F)F)(Cl)Br

Isomeric SMILES

No data

International Chemical Identifier key (InChIKey)

BCQZXOMGPXTTIC-UHFFFAOYSA-N

International Chemical Identifier (InChI)

InChI=1S/C2HBrClF3/c3-1(4)2(5,6)7/h1H

2D structure diagram/image available?

Yes

Cambridge Crystallographic Data Centre diagrams

Common Name	Relationship	Link
halothane	-

General status

Veterinary substance type

Anesthesetic

Substance groups

Halogenated alkane

Minimum active substance purity

Known relevant impurities

Substance origin

Synthetic

Mode of action

Involves interactions with multiple receptor sites to interfere with synaptic transmission.

Molecular targets

[Potassium channel subfamily K member 3, binder], [Potassium channel subfamily K member 9, binder], [Calcium-activated potassium channel subunit alpha 1, inhibitor], [Glutamate [NMDA] receptor subunit 3A, inhibitor], [Glutamate [NMDA] receptor subunit 3B, inhibitor], [Glutamate [NMDA] receptor subunit epsilon-1, inhibitor], [Glycine receptor subunit alpha-1, modulator], [Rhodopsin], [G protein-activated inward rectifier potassium channel 2, inhibitor], [G protein-activated inward rectifier potassium channel 1, inhibitor], [NADH-ubiquinone oxidoreductase chain 1, inhibitor], [Intermediate conductance calcium-activated potassium channel protein 4, inhibitor], [ ATP synthase delta chain, mitochondrial], [Calcium-transporting ATPase type 2C member 1], [Gamma-aminobutyric-acid (GABA) receptor subunit alpha-1], [Guanine nucleotide-binding protein G(I)/G(S)/G(O) gamma-2 subunit], [Neuropeptide S receptor]

CAS RN

151-67-7

EC number

205-796-5

CIPAC number

US EPA chemical code

PubChem CID

ATCvet Code

QN01AB01

Therapeutic Class

Nervous system: Anaesthetics

Controlled Drug?

Regulation 37/2010 MRL Classification

No data

Molecular mass

197.38

PIN (Preferred Identification Name)

IUPAC name

2-bromo-2-chloro-1,1,1-trifluoroethane

CAS name

1,1,1-trifluoro-2-bromo-2-chloroethane

Other status information

Relevant Environmental Water Quality Standards

Physical state

Colourless volatile liquid

Formulations

Property

Product

Manufacturer

Authorisation Route

UK Legal Class

Example products using this active

Halothane-Vet 100% Inhalation vapour, liquid

Merial Animal Health Ltd

UK National authorisation

Prescription only medicine to be authorised by a veterinarian (POM-V)

Formulation and application details

Usually supplied as a liquid from which vapours are inhaled

ENVIRONMENTAL FATE

Property

Value

Source; quality score; and other information

Interpretation

Solubility - In water at 20 °C (mg l⁻¹)

4070

High

Solubility - In organic solvents at 20 °C (mg l⁻¹)

Melting point (°C)

-118

Boiling point (°C)

50.2

Degradation point (°C)

Flashpoint (°C)

Octanol-water partition coefficient at pH 7, 20 °C

2.00 X 10⁰²

Calculated

Log P

2.3

Low

Fat solubility of residues

Solubility

Data type

Density (g ml⁻¹)

1.87

Dissociation constant pKa) at 25 °C

Vapour pressure at 20 °C (mPa)

4.02 X 10⁰⁷

Highly volatile

Henry's law constant at 25 °C (Pa m³ mol⁻¹)

Maximum UV-vis absorption L mol⁻¹ cm⁻¹

Surface tension (mN m⁻¹)

Refractive Index

Degradation

Property

Value

Source; quality score; and other information

Interpretation

Soil degradation (days) (aerobic)

DT₅₀ (typical)

DT₅₀ (lab at 20 °C)

DT₅₀ (field)

DT₉₀ (lab at 20 °C)

DT₉₀ (field)

Note

Manure DT₅₀ (days)

Aqueous photolysis DT₅₀ (days) at pH 7

Value

Note

Aqueous hydrolysis DT₅₀ (days) at 20 °C and pH 7

Value

Note

Water-sediment DT₅₀ (days)

Water phase only DT₅₀ (days)

Soil adsorption and mobility

Property

Value

Source; quality score; and other information

Interpretation

Linear

K_d

K_oc

Notes and range

Freundlich

K_f

K_foc

¹/_n

Notes and range

pH sensitivity

Fate indices

Property

Value

Source; quality score; and other information

Interpretation

GUS leaching potential index

Bio-concentration factor

BCF (l kg⁻¹)

CT₅₀ (days)

Known soil and groundwater metabolites

None

Other known metabolites

Metabolite name and reference

Aliases

Formation medium / Rate

Estimated maximum occurrence fraction

Metabolising enzymes

bromide

Humans (Liver)

Cytochrome P450 2E1 (Some involvement of CYP3A4 & CYP2A6)

trifluoroacetic acid

Humans (Liver)

Cytochrome P450 2E1 (Some involvement of CYP3A4 & CYP2A6)

ECOTOXICOLOGY

Terrestrial ecotoxicology

Property

Value

Source; quality score; and other information

Interpretation

Mammals - Acute oral LD₅₀ (mg kg⁻¹)

> 5680

Rat

Low

Mammals - Short term dietary NOEL

(mg kg⁻¹)

(ppm diet)

Mammals - Chronic 21d NOAEL (mg kg⁻¹ bw d⁻¹)

Birds - Acute LD₅₀ (mg kg⁻¹)

Birds - Short term dietary (LC₅₀/LD₅₀)

Birds - Chronic 21d NOEL (mg kg⁻¹ bw d⁻¹)

Earthworms - Acute 14 day LC₅₀ (mg kg⁻¹)

Earthworms - Chronic NOEC, reproduction (mg kg⁻¹)

Soil micro-organisms

Collembola

Acute LC₅₀ (mg kg⁻¹)

Chronic NOEC (mg kg⁻¹)

Non-target plants

Honeybees (Apis spp.)

Contact acute LD₅₀ (worst case from 24, 48 and 72 hour values - μg bee⁻¹)

Oral acute LD₅₀ (worst case from 24, 48 and 72 hour values - μg bee⁻¹)

Unknown mode acute LD₅₀ (worst case from 24, 48 and 72 hour values - μg bee⁻¹)

Chronic

Bumblebees (Bombus spp.)

Contact acute LD₅₀ (worst case from 24, 48 and 72 hour values - μg bee⁻¹)

Oral acute LD₅₀ (worst case from 24, 48 and 72 hour values - μg bee⁻¹)

Mason bees (Osmia spp.)

Contact acute LD₅₀ (worst case from 24, 48 and 72 hour values - μg bee⁻¹)

Oral acute LD₅₀ (worst case from 24, 48 and 72 hour values - μg bee⁻¹)

Other bee species (1)

Acute LD₅₀ (worst case from 24, 48 and 72 hour values - μg insect⁻¹)

Mode of exposure

Other bee species (2)

Acute LD₅₀ (worst case from 24, 48 and 72 hour values - μg insect⁻¹)

Mode of exposure

Beneficial insects (Ladybirds)

Beneficial insects (Lacewings)

Beneficial insects (Parasitic wasps)

Beneficial insects (Predatory mites)

Beneficial insects (Ground beetles)

Aquatic ecotoxicology

Property

Value

Source; quality score; and other information

Interpretation

Fish - Acute 96 hour LC₅₀ (mg l⁻¹)

Fish - Chronic 21 day NOEC (mg l⁻¹)

Aquatic invertebrates - Acute 48 hour EC₅₀ (mg l⁻¹)

Aquatic invertebrates - Chronic 21 day NOEC (mg l⁻¹)

Aquatic crustaceans - Acute 96 hour LC₅₀ (mg l⁻¹)

Sediment dwelling organisms - Acute 96 hour LC₅₀ (mg l⁻¹)

Sediment dwelling organisms - Chronic 28 day NOEC, static, water (mg l⁻¹)

Sediment dwelling organisms - Chronic 28 day NOEC, sediment (mg kg⁻¹)

Aquatic plants - Acute 7 day EC₅₀, biomass (mg l⁻¹)

Algae - Acute 72 hour EC₅₀, growth (mg l⁻¹)

Algae - Chronic 96 hour NOEC, growth (mg l⁻¹)

Mesocosm study data

NOEAEC mg l⁻¹

HUMAN HEALTH AND PROTECTION

General

Property

Value

Source; quality score; and other information

Interpretation

Threshold of Toxicological Concern (Cramer Class)

High (class III)

Mammals - Acute oral LD₅₀ (mg kg⁻¹)

> 5680

Rat

Low

Mammals - Dermal LD₅₀ (mg kg⁻¹ body weight)

Mammals - Inhalation LC₅₀ (mg l⁻¹)

29.0

Rat

Other Mammal toxicity endpoints

Intravenous LD₅₀ = 129 mg kg⁻¹

Human

ADI - Acceptable Daily Intake (mg kg⁻¹ bw day⁻¹)

ARfD - Acute Reference Dose (mg kg⁻¹ bw day⁻¹)

AAOEL - Acute Acceptable Operator Exposure Level (mg kg⁻¹ bw day⁻¹)

AOEL - Acceptable Operator Exposure Level - Systemic (mg kg⁻¹ bw day⁻¹)

Dermal penetration studies (%)

Dangerous Substances Directive 76/464

Exposure Routes

Public

Occupational

Mammalian dose elimination route and rate

Mainly eliminated via the lungs

Health issues

Specific human health issues

Carcinogen

Genotoxic

Endocrine disruptor

; ; ; ;

No data found

Reproduction / development effects

Acetyl cholinesterase inhibitor

Neurotoxicant

No data found

Respiratory tract irritant

Skin irritant

Skin sensitiser

No data found

Eye irritant

Phototoxicant

No data found

General human health issues

Strong respiratory depressant
May cause cardiac arrest, hypotension, respiratory arrest, cardiac arrhythmias, hyperpyrexia, shivering, nausea

Handling issues

Property

Value and interpretation

General

Non-flammable, highly volatile

CLP classification 2013

WHO Classification

Not listed (Not listed)

UN Number

Waste disposal & packaging

Shelf-life, storage, stability and reactivity

TRANSLATIONS

Language

Name

English

halothane

French

German

Danish

Italian

Spanish

halotano

Greek

Polish

Swedish

Hungarian

Dutch

Norwegian

Record last updated:	15/04/2021
Contact:	aeru@herts.ac.uk
Please cite as:	Lewis, K.A., Tzilivakis, J., Warner, D. and Green, A. (2016) An international database for pesticide risk assessments and management. Human and Ecological Risk Assessment: An International Journal, 22(4), 1050-1064. DOI: 10.1080/10807039.2015.1133242